EUGENIA MAGAHIS: Open Payments
NPI 1023419686 · EMERYVILLE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$202 in 4 payments from 4 companies in 2025. Trend: 2023 $406 · 2024 $76 · 2025 $202
Food & beverage: $202
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 1 | $125 |
| Otsuka America Pharmaceutical, Inc. | 1 | $35 |
| Lilly USA, LLC | 1 | $27 |
| Lundbeck LLC | 1 | $15 |
Products named: Trodelvy, REXULTI, ZEPBOUND.
Industry payments across CA — which companies pay providers there.
